Bell Potter recently valued Immutep as buy rating and thinks this biotechnologycompany could be a great option for investors with a high tolerance for currently has a speculative buy rating and 80 cents price target. A couple trials of IMM are phase 2 and 3.
while why not Imugene? The main issue of IMU, too early stage for current trials on phase 1 or 2. Her-vaxx supposed to be phase 2-3 to be successful while disappear? Can’t hold on it to say it.
Bell Potter recently valued Immutep as buy rating and thinks...
-
- There are more pages in this discussion • 1,531 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $402.5M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.7¢ | 5.4¢ | $1.042M | 18.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 628179 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 897037 | 6 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |